Prevention of Seasonal Affective Disorder

This study has been completed.
Information provided by:
GlaxoSmithKline Identifier:
First received: September 30, 2002
Last updated: July 26, 2010
Last verified: July 2010

A Placebo Controlled Study Evaluating The Effectivess Of Medication In Preventing Seasonal Affective Disorder

Condition Intervention Phase
Seasonal Affective Disorder (SAD)
Drug: Investigational Seasonal Affective Disorder (SAD) Drug
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double-Blind
Primary Purpose: Treatment

Resource links provided by NLM:

Further study details as provided by GlaxoSmithKline:


Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria: (Patient must meet these criteria in order to be eligible for this study.)

  • Patient has a history of Major Depressive Disorder (MDD) with a seasonal pattern.

Exclusion Criteria: (Patient cannot meet these criteria in order to be eligible for this study.)

  • Patient has a current or past history of seizure disorder or brain injury.
  • Patient has a history or current diagnosis of anorexia nervousa or bulimia.
  • Patient has recurrent summer depression more frequently than winter depression.
  • Patient has primary diagnosis of panic disorder, Obsessive Compulsive Disorder (OCD), Posttraumatic Stress Disorder (PTSD), acute distress disorder, bipolar II disorder or other psychotic disorders.
  • Patient has initiated psychotherapy within the last 3 months.
  Contacts and Locations
Please refer to this study by its identifier: NCT00046449

  Show 54 Study Locations
Sponsors and Collaborators
  More Information

No publications provided Identifier: NCT00046449     History of Changes
Obsolete Identifiers: NCT00300144
Other Study ID Numbers: 398149
Study First Received: September 30, 2002
Last Updated: July 26, 2010
Health Authority: United States: Food and Drug Administration

Additional relevant MeSH terms:
Seasonal Affective Disorder
Mood Disorders
Depressive Disorder
Mental Disorders processed this record on April 17, 2014